Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...

Mechanisms of aluminium neurotoxicity in oxidative stress-induced ... Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...

dspace.usc.es
from dspace.usc.es More from this publisher
28.11.2012 Views

REFERENCES Ghribi O., Dewitt D. A., Forbes M. S., Herman M. M. and Savory J. (2001b) Co-involvement of 198 mitochondria and endoplasmic reticulum in regulation of apoptosis: changes in cytochrome-c, Bcl-2 and Bax in the hippocampus of Aluminium treated rabbits. Brain Res. 8, 764–773. Ghribi O., Herman M. M., DeWitt D. A., Forbes M. S. and Savory J. (2001c) Abeta(1–42) and aluminium induce stress in the endoplasmic reticulum in rabbit hippocampus, involving nuclear translocation of gadd 153 and NF-kappaB. Brain Res. Mol. Brain Res. 96, 30–38. Ghribi O., Herman M. M. and Savory J. (2002) The endoplasmic reticulum is the main site for Caspase-3 activation following aluminium-induced neurotoxicity in rabbit hippocampus. Neurosci. Lett. 324, 217–221. Giasson B. I. and Lee V. M. (2000) A new link between pesticides and Parkinson’s disease. Nat. Neurosci. 3, 1227–1228. Giasson B. I., Duda J. E., Murray I. V., Chen Q., Souza J. M., Hurtig H. I., Ischiropoulos H., Trojanowski J. Q. and Lee V. M. (2000) Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 290, 985–989. Gibb W. R. and Lees A. J. (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry 51, 745–752. Gitelman H. J., Aldernan F. R., Jurs-Lasky M. and Rockette H. E. (1995) Serum and urinary aluminum levels of workers in the aluminum industry. Ann. Occup. Hyg. 39, 181–191. Giuffra M. E., Sethy V. H., Davis T. L., Mouradian M. M. and Chase T. N. (1993) Milacemide therapy for Parkinson's disease. Mov. Disord. 8, 47–50. Glinka Y. Y. and Youdim M. B. (1995) Inhibition of mitochondrial complexes I and IV by 6- hydroxydopamine. Eur. J. Pharmacol. 292, 329–332. Glinka Y., Tipton K. F. and Youdim M. B. (1996) Nature of inhibition of mitochondrial respiratory complex I by 6-hydroxydopamine. J. Neurochem. 66, 2004–2010.

REFERENCES Glinka Y., Tipton K. F. and Youdim M. B. H. (1998) Mechanism of inhibition of mitochondrial respiratory complex I by 6-hydroxydopamine and its prevention by desferrioxamine. Eur. J. Pharmacol. 351, 121–129. Goedert M. (2001) Alpha-synuclein and neurodegenerative diseases. Nat. Rev. Neurosci. 2, 492–501. Goetz M. E. and Gerlach M. (2004) Formation of radicals, in Brain damage and repair, (Herdegen T. and Delgado-Garcia J., eds), pp. 135–164,. Kluwer, London. Goldberg M. S., Fleming S. M., Palacino J. J., Cepeda C., Lam H. A., Bhatnagar A., Meloni E. G., Wu N., Ackerson L. C., Klapstein G. J., Gajendiran M., Roth B. L., Chesselet M. F., Maidment N. T., Levine M. S. and Shen J. (2003) Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J. Biol. Chem. 278, 43628–43635. Golub M. S., Germann S. L., Han B. and Keen C. L. (2000) Lifelong feeding of a high aluminum diet to mice. Toxicology 150, 107–117. Gómez M., Esparza J. L., Domingo J. L., Singh P. K. and Jones M. M. (1999) Chelation therapy in aluminum-loaded rats: influence of age. Toxicology 137, 161–168. Gómez M., Esparza J. L., Nogués M. R., Giralt M., Cabré M. and Domingo JL. (2005) Pro-oxidant activity of aluminum in the rat hippocampus: gene expression of antioxidant enzymes after melatonin administration. Free Radic. Biol. Med. 38, 104–11. Gonçalves P. P. and Silva V. S. (2007) Does neurotransmission impairment accompany aluminium neurotoxicity? J. Inorg. Biochem. 101, 1291–1338. González-Muñoz M. J., Meseguer I., Sanchez-Reus M. I., Schultz A., Olivero R., Benedí R. J. and Sánchez-Muniz F. J. (2008) Beer consumption reduces cerebral oxidation caused by aluminum toxicity by normalizing gene expression of tumor necrotic factor alpha and several antioxidant enzymes. Food Chem. Toxicol. 46, 1111–1118. 199

REFERENCES<br />

Ghribi O., Dewitt D. A., Forbes M. S., Herman M. M. and Savory J. (2001b) Co-<strong>in</strong>volvement <strong>of</strong><br />

198<br />

mitochondria and endoplasmic reticulum <strong>in</strong> regulation <strong>of</strong> apoptosis: changes <strong>in</strong><br />

cytochrome-c, Bcl-2 and Bax <strong>in</strong> the hippocampus <strong>of</strong> Alum<strong>in</strong>ium treated rabbits. Bra<strong>in</strong> Res.<br />

8, 764–773.<br />

Ghribi O., Herman M. M., DeWitt D. A., Forbes M. S. and Savory J. (2001c) Abeta(1–42) and<br />

<strong>alum<strong>in</strong>ium</strong> <strong>in</strong>duce <strong>stress</strong> <strong>in</strong> the endoplasmic reticulum <strong>in</strong> rabbit hippocampus, <strong>in</strong>volv<strong>in</strong>g<br />

nuclear translocation <strong>of</strong> gadd 153 and NF-kappaB. Bra<strong>in</strong> Res. Mol. Bra<strong>in</strong> Res. 96, 30–38.<br />

Ghribi O., Herman M. M. and Savory J. (2002) The endoplasmic reticulum is the ma<strong>in</strong> site for<br />

Caspase-3 activation follow<strong>in</strong>g <strong>alum<strong>in</strong>ium</strong>-<strong>in</strong>duced <strong>neurotoxicity</strong> <strong>in</strong> rabbit hippocampus.<br />

Neurosci. Lett. 324, 217–221.<br />

Giasson B. I. and Lee V. M. (2000) A new l<strong>in</strong>k between pesticides and Park<strong>in</strong>son’s disease. Nat.<br />

Neurosci. 3, 1227–1228.<br />

Giasson B. I., Duda J. E., Murray I. V., Chen Q., Souza J. M., Hurtig H. I., Ischiropoulos H.,<br />

Trojanowski J. Q. and Lee V. M. (2000) Oxidative damage l<strong>in</strong>ked to neurodegeneration by<br />

selective alpha-synucle<strong>in</strong> nitration <strong>in</strong> synucle<strong>in</strong>opathy lesions. Science 290, 985–989.<br />

Gibb W. R. and Lees A. J. (1988) The relevance <strong>of</strong> the Lewy body to the pathogenesis <strong>of</strong><br />

idiopathic Park<strong>in</strong>son’s disease. J. Neurol. Neurosurg. Psychiatry 51, 745–752.<br />

Gitelman H. J., Aldernan F. R., Jurs-Lasky M. and Rockette H. E. (1995) Serum and ur<strong>in</strong>ary<br />

alum<strong>in</strong>um levels <strong>of</strong> workers <strong>in</strong> the alum<strong>in</strong>um <strong>in</strong>dustry. Ann. Occup. Hyg. 39, 181–191.<br />

Giuffra M. E., Sethy V. H., Davis T. L., Mouradian M. M. and Chase T. N. (1993) Milacemide<br />

therapy for Park<strong>in</strong>son's disease. Mov. Disord. 8, 47–50.<br />

Gl<strong>in</strong>ka Y. Y. and Youdim M. B. (1995) Inhibition <strong>of</strong> mitochondrial complexes I and IV by 6-<br />

hydroxydopam<strong>in</strong>e. Eur. J. Pharmacol. 292, 329–332.<br />

Gl<strong>in</strong>ka Y., Tipton K. F. and Youdim M. B. (1996) Nature <strong>of</strong> <strong>in</strong>hibition <strong>of</strong> mitochondrial<br />

respiratory complex I by 6-hydroxydopam<strong>in</strong>e. J. Neurochem. 66, 2004–2010.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!